Literature DB >> 18300582

Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.

Nicola Bassi1, Daniela Amital, Howard Amital, Andrea Doria, Yehuda Shoenfeld.   

Abstract

Chronic fatigue syndrome is a heterogeneous disorder with unknown pathogenesis and etiology, characterized by disabling fatigue, difficulty in concentration and memory, and concomitant skeletal and muscular pain. Several mechanisms have been suggested to play a role in CFS, such as excessive oxidative stress following exertion, immune imbalance characterized by decreased natural killer cell and macrophage activity, immunoglobulin G subclass deficiencies (IgG1, IgG3) and decreased serum concentrations of complement component. Autoantibodies were also suggested as a possible factor in the pathogenesis of CFS. Recent studies indicate that anti-serotonin, anti-microtubule-associated protein 2 and anti-muscarinic cholinergic receptor 1 may play a role in the pathogenesis of CFS. It has been demonstrated that impairment in vasoactive neuropeptide metabolism may explain the symptoms of CFS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300582

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  13 in total

Review 1.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

2.  Activity Pacing Self-Management in Chronic Fatigue Syndrome: A Randomized Controlled Trial.

Authors:  Daphne Kos; Inge van Eupen; Jill Meirte; Deborah Van Cauwenbergh; Greta Moorkens; Mira Meeus; Jo Nijs
Journal:  Am J Occup Ther       Date:  2015 Sep-Oct

3.  Chronic fatigue syndrome and complement activation.

Authors:  Robert Dennis Geller; Patricia C Giclas
Journal:  BMJ Case Rep       Date:  2009-03-17

Review 4.  The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

5.  Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis.

Authors:  Amy D Proal; Paul J Albert; Trevor G Marshall; Greg P Blaney; Inge A Lindseth
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 6.  Chronic fatigue syndrome: aetiology, diagnosis and treatment.

Authors:  Alfredo Avellaneda Fernández; Alvaro Pérez Martín; Maravillas Izquierdo Martínez; Mar Arruti Bustillo; Francisco Javier Barbado Hernández; Javier de la Cruz Labrado; Rafael Díaz-Delgado Peñas; Eduardo Gutiérrez Rivas; Cecilia Palacín Delgado; Javier Rivera Redondo; José Ramón Ramón Giménez
Journal:  BMC Psychiatry       Date:  2009-10-23       Impact factor: 3.630

7.  Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial.

Authors:  Hyeong-Geug Kim; Jung-Hyo Cho; Sa-Ra Yoo; Jin-Seok Lee; Jong-Min Han; Nam-Hun Lee; Yo-Chan Ahn; Chang-Gue Son
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

Review 8.  A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.

Authors:  Gerwyn Morris; George Anderson; Piotr Galecki; Michael Berk; Michael Maes
Journal:  BMC Med       Date:  2013-03-08       Impact factor: 8.775

Review 9.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

10.  The aetiopathogenesis of fatigue: unpredictable, complex and persistent.

Authors:  James E Clark; W Fai Ng; Stuart Watson; Julia L Newton
Journal:  Br Med Bull       Date:  2016-02-12       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.